ISIN | LU1585228379 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Emerging Markets Healthcare I2 |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) |
Bank am Bellevue AG Küsnacht Phone: +41 44 267 67 67 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
Peculiarities |
Current Price * | 130.87 USD | 10.06.2025 |
---|---|---|
Previous Price * | 126.68 USD | 06.06.2025 |
52 Week High * | 139.34 USD | 04.10.2024 |
52 Week Low * | 108.93 USD | 09.04.2025 |
NAV * | 130.87 USD | 10.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 65,892,265 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | +12.37% |
30.12.2024 - 10.06.2025
30.12.2024 10.06.2025 |
---|---|---|
YTD Performance (in CHF) | +2.23% |
30.12.2024 - 10.06.2025
30.12.2024 10.06.2025 |
1 month | +11.23% |
12.05.2025 - 10.06.2025
12.05.2025 10.06.2025 |
3 months | +13.37% |
10.03.2025 - 10.06.2025
10.03.2025 10.06.2025 |
6 months | +9.91% |
10.12.2024 - 10.06.2025
10.12.2024 10.06.2025 |
1 year | +12.12% |
11.06.2024 - 10.06.2025
11.06.2024 10.06.2025 |
2 years | -8.14% |
12.06.2023 - 10.06.2025
12.06.2023 10.06.2025 |
3 years | -10.00% |
10.06.2022 - 10.06.2025
10.06.2022 10.06.2025 |
5 years | -47.58% |
15.06.2021 - 10.06.2025
15.06.2021 10.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Celltrion Inc | 6.57% | |
---|---|---|
BeOne Medicines Ltd Ordinary Shares | 5.90% | |
Sun Pharmaceuticals Industries Ltd | 5.87% | |
Samsung BioLogics Co Ltd | 4.97% | |
WuXi Biologics (Cayman) Inc | 4.11% | |
Rede d or Sao Luiz SA Ordinary Shares | 4.07% | |
Sino Biopharmaceutical Ltd | 3.94% | |
Innovent Biologics Inc | 3.72% | |
Cipla Ltd | 3.28% | |
Akeso Inc Ordinary Shares | 3.20% | |
Last data update | 31.05.2025 |
TER | 1.51% |
---|---|
TER date | 29.01.2021 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 1.38% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |